4 Incretin Mimetic Defendants Get $683,440 In Costs Following Summary Judgment

(February 19, 2016, 2:16 PM EST) -- SAN DIEGO — The California federal court overseeing the incretin mimetics multidistrict litigation on Feb. 18 awarded $683,440 in costs to four defendants following a November summary judgment in their favor (In Re: Incretin-Based Therapies Products Liability Litigation, MDL Docket No. 2452, No. 13-md-2452, S.D. Calif.).

(Costs order available. Document #28-160303-003R.)

In an order signed by a court clerk in the U.S. District Court for the Southern District of California, defendant Merck, Sharpe & Dohme was awarded $68,183 of the $87,556 in costs it sought. Defendant...
To view the full article, register now.